Please Wait.....
Report
Blue Biotechnology Market Research Report Information by Product (Enzymes, Pharma Products, Bulk Chemicals, and Others), by Application (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatment Services, and Others), and by End User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032
Market Report I 2024-08-10 I 131 Pages I Market Research Future
Blue Biotechnology Market Research Report Information by Product (Enzymes, Pharma Products, Bulk Chemicals, and Others), by Application (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatment Services, and Others), and by End User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032
Market Overview
During the forecast period (2024-2032), the Blue Biotechnology Market industry is anticipated to experience a compound annual growth rate (CAGR) of 7.15%, increasing from USD 5.65 billion in 2024 to USD 10.54 billion by 2032. Strategic initiatives associated with pharmaceuticals and nutraceuticals sourced from marine organisms, as well as the growing awareness of blue biotechnology-based nutraceuticals and pharmaceuticals, are the factors that are fueling the growth of the global market.
The blue biotechnology market is experiencing significant development as a result of the growing recognition of nutraceuticals and pharmaceuticals that are based on blue biotechnology. The demand for products derived from marine organisms is increasing as consumers become more aware of the health benefits provided by marine-derived compounds. The perceived health-promoting properties of nutraceuticals that contain marine ingredients, such as omega-3 fatty acids, antioxidants, and minerals, are causing them to acquire popularity.
In addition, the Blue Biotechnology Market is being significantly influenced by the rise in strategic initiatives that are focused on pharmaceutical and nutraceutical products that are derived from marine organisms. The pharmaceutical and nutraceutical industries have shifted their attention to the oceans' vast and largely untapped resources as they seek new methods to meet evolving healthcare and dietary needs.
Market segment insights
The Blue Biotechnology Market is segmented into enzymes, pharma products, bulk chemicals, biopolymers, and others based on product.
The Blue Biotechnology Market has been categorized into the following by type: bioengineering, genomics, vaccine development, drug discovery, fisheries, aquaculture, biofuels, water purification services, and others.
The blue biotechnology market is segmented into hospitals, pharmaceutical companies, biotechnology companies, and others based on the end user.
Regional Perspectives
The market is segmented into four regions: North America, Europe, Asia-Pacific, and the Rest of the World. In 2023, North America held the largest market share of over 36.04%, which was attributed to the presence of established drug manufacturers, advanced healthcare infrastructure, and increased investment in research and development activities. Furthermore, the region's market growth is being stimulated by the active involvement of renowned market actors in meeting consumer demand.
The blue biotechnology market in Europe is expected to experience substantial growth during the forecast year, 2024-2032, because of the substantial number of start-ups that are associated with blue biotechnology. For example, the Oceano Azul Foundations and Calouste Gulbenkian, both of which are based in Portugal, received over 120 projects from more than 30 countries that were associated with blue biotechnology by September 2020.
The Asia-Pacific blue biotechnology market is the fastest-growing region during the forecast period due to the high demand for marine-derived products in a variety of industries, including agriculture, pharmaceuticals, and cosmetics. Additionally, the market is experiencing significant growth because of the development of biotechnological tools and techniques, including genomics, proteomics, and metabolomics, which have facilitated the investigation and exploitation of marine resources. These technologies enable researchers to more effectively identify, isolate, and produce valuable compounds from marine organisms.
Major Players
Marinomed Biotech AG (Austria), Marshall Marine Products (India), Marinova (Australia), Aker BioMarine (Norway), Pharma Mar (Spain), Cyanotech Corporation (US), ADM (US), Geomarine (India), CP Kelco U.S., Inc. (US), and TerSera Therapeutics LLC (US) are among the key companies in the Blue Biotechnology Market.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING AWARENESS OF BLUE BIOTECHNOLOGY-BASED NUTRACEUTICALS AND PHARMACEUTICALS
4.2.2 RISING STRATEGIC INITIATIVES ASSOCIATED WITH PHARMACEUTICALS AND NUTRACEUTICALS SOURCED FROM MARINE ORGANISMS
4.3 RESTRAINTS
4.3.1 STRINGENT REGULATORY POLICIES
4.4 OPPORTUNITIES
4.4.1 INCREASING INVESTMENT IN THE DEVELOPMENT OF BIOTECHNOLOGY-BASED MEDICINE
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON THE INDIA CELL CULTURE MEDIA MARKET
5.2.1 IMPACT ON SUPPLY CHAIN
6 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 ENZYMES
6.3 PHARMA PRODUCTS
6.4 BULK CHEMICALS
6.5 BIOPOLYMERS
6.6 OTHERS
7 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 BIOENGINEERING
7.3 GENOMICS
7.4 VACCINE DEVELOPMENT
7.5 DRUG DISCOVERY
7.6 FISHERIES
7.7 AQUACULTURE
7.8 BIOFUELS
7.9 WATER TREATMENT SERVICES
7.10 OTHERS
8 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 PHARMACEUTICAL COMPANIES
8.4 BIOTECHNOLOGY COMPANIES
8.5 OTHERS
9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 NORWAY
9.3.7 NETHERLANDS
9.3.8 SWITZERLAND
9.3.9 FINLAND
9.3.10 BELGIUM
9.3.11 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 INDIA
9.4.3 JAPAN
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST
9.5.3 AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE BLUE BIOTECHNOLOGY MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE BLUE BIOTECHNOLOGY MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 PRODUCT LAUNCH / PRODUCT APPROVAL
10.6.2 AGREEMENT
10.6.3 PARTNERSHIP
10.6.4 ACQUISITION
10.7 MAJOR PLAYERS FINANCIAL
10.7.1 SALES (USD MILLION), 2023
10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2023
11 COMPANY PROFILES
11.1 MARINOMED BIOTECH AG
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 KEY STRATEGIES
11.2 MARSHALL MARINE PRODUCTS/
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIES
11.3 MARINOVA
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 AKER BIOMARINE
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 PHARMAMAR
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 CYANOTECH CORPORATION
11.6.1 COMPANY OVERVIEWS
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIES
11.7 ADM
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL ANALYSIS
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 GEOMARINE BIOTECHNOLOGIES
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 CP KELCO U.S., INC.
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCT OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 TERSERA THERAPEUTICS LLC
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 SWOT ANALYSIS
11.10.6 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 4 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR ENZYMES, BY REGION, 2019-2032 (USD MILLION)
TABLE 5 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR PHARMA PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
TABLE 6 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BULK CHEMICALS, BY REGION, 2019-2032 (USD MILLION)
TABLE 7 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOPOLYMERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 8 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 10 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOENGINEERING, BY REGION, 2019-2032 (USD MILLION)
TABLE 11 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR GENOMICS, BY REGION, 2019-2032 (USD MILLION)
TABLE 12 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR VACCINE DEVELOPMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 13 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR DRUG DISCOVERY, BY REGION, 2019-2032 (USD MILLION)
TABLE 14 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR FISHERIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 15 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR AQUACULTURE, BY REGION, 2019-2032 (USD MILLION)
TABLE 16 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOFUELS, BY REGION, 2019-2032 (USD MILLION)
TABLE 17 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR WATER TREATMENT SERVICES, BY REGION, 2019-2032 (USD MILLION)
TABLE 18 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 19 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 20 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR HOSPITALS, BY REGION, 2019-2032 (USD MILLION)
TABLE 21 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 22 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 23 GLOBAL BLUE BIOTECHNOLOGY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 24 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 25 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 26 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 27 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 28 US: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 29 US: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 30 US: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 31 CANADA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 32 CANADA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 33 CANADA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 34 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 35 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 36 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 37 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 38 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 39 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 40 GERMANY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 41 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 42 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 43 FRANCE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 44 UK: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 45 UK: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 46 UK: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 47 ITALY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 48 ITALY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 49 ITALY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 50 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 51 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 52 SPAIN: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 53 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 54 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 55 NORWAY: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 56 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 57 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 58 NETHERLANDS: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 59 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 60 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 61 SWITZERLAND: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 62 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 63 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 64 FINLAND: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 65 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 66 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 67 BELGIUM: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 68 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 69 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 70 REST OF EUROPE: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 71 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 72 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 73 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 74 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 75 CHINA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 76 CHINA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 77 CHINA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 78 INDIA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 79 INDIA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 80 INDIA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 81 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 82 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 83 JAPAN: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 84 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 85 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 86 AUSTRALIA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 87 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 88 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 89 SOUTH KOREA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 90 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 91 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 92 REST OF ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 93 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 94 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 95 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 96 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 97 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 98 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 99 LATIN AMERICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 100 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 101 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 102 MIDDLE EAST: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 103 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 104 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 105 AFRICA: BLUE BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 106 MAJOR PLAYERS IN THE BLUE BIOTECHNOLOGY MARKET
TABLE 107 MOST ACTIVE PLAYER IN THE BLUE BIOTECHNOLOGY MARKET
TABLE 108 PRODUCT LAUNCH / PRODUCT APPROVAL
TABLE 109 AGREEMENT
TABLE 110 PARTNERSHIP
TABLE 111 ACQUISITION
TABLE 112 MARINOMED BIOTECH AG: PRODUCTS OFFERED
TABLE 113 MARINOMED BIOTECH AG: KEY DEVELOPMENTS
TABLE 114 MARSHALL MARINE PRODUCTS: PRODUCTS OFFERED
TABLE 115 MARINOVA: PRODUCTS OFFERED
TABLE 116 AKER BIOMARINE: PRODUCTS OFFERED
TABLE 117 AKER BIOMARINE.: KEY DEVELOPMENTS
TABLE 118 PHARMAMAR: PRODUCTS OFFERED
TABLE 119 PHARMAMAR: KEY DEVELOPMENTS
TABLE 120 CYANOTECH CORPORATION: PRODUCTS OFFERED
TABLE 121 CYANOTECH CORPORATION: KEY DEVELOPMENTS
TABLE 122 ADM: PRODUCTS OFFERED
TABLE 123 GEOMARINE BIOTECHNOLOGIES: PRODUCTS OFFERED
TABLE 124 CP KELCO U.S., INC.: PRODUCT OFFERED
TABLE 125 TERSERA THERAPEUTICS LLC: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL BLUE BIOTECHNOLOGY MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE BLUE BIOTECHNOLOGY MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: INDIA CELL CULTURE MEDIA MARKET
FIGURE 8 GLOBAL BLUE BIOTECHNOLOGY MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 9 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY PRODUCT, 2023
FIGURE 11 GLOBAL BLUE BIOTECHNOLOGY MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 12 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
FIGURE 13 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY APPLICATION, 2023
FIGURE 14 GLOBAL BLUE BIOTECHNOLOGY MARKET, END USER SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
FIGURE 15 GLOBAL BLUE BIOTECHNOLOGY MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 16 GLOBAL BLUE BIOTECHNOLOGY MARKET SHARE (%), BY END USER, 2023
FIGURE 17 NORTH AMERICA MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 18 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 NORTH AMERICA: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 20 EUROPE MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 21 EUROPE: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 22 EUROPE: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 24 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 25 ASIA-PACIFIC: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 26 REST OF THE WORLD MARKET ANALYSIS: BLUE BIOTECHNOLOGY MARKET, 2019-2032 (USD MILLION)
FIGURE 27 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 28 REST OF THE WORLD: BLUE BIOTECHNOLOGY MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 29 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 30 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE BLUE BIOTECHNOLOGY MARKET
FIGURE 31 BLUE BIOTECHNOLOGY MARKET: COMPETITIVE LANDSCAPE
FIGURE 32 MAJOR PLAYERS SALES (USD MILLION), 2023
FIGURE 33 MAJOR PLAYER R&D EXPENDITURE (USD MILLION), 2023
FIGURE 34 MARINOMED BIOTECH AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 MARINOVA: SWOT ANALYSIS
FIGURE 36 AKER BIOMARINE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 AKER BIOMARINE: SWOT ANALYSIS
FIGURE 38 PHARMAMAR: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 PHARMAMAR: SWOT ANALYSIS
FIGURE 40 CYANOTECH CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 ADM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 ADM: SWOT ANALYSIS
FIGURE 43 TERSERA THERAPEUTICS LLC: SWOT ANALYSIS
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security